Azenta Cost of Goods Sold 2010-2024 | AZTA
Azenta cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| Azenta Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $402 |
| 2022 | $300 |
| 2021 | $270 |
| 2020 | $216 |
| 2019 | $200 |
| 2018 | $385 |
| 2017 | $329 |
| 2016 | $277 |
| 2015 | $364 |
| 2014 | $316 |
| 2013 | $290 |
| 2012 | $330 |
| 2011 | $465 |
| 2010 | $427 |
| 2009 | $225 |
| Azenta Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-06-30 | $104 |
| 2024-03-31 | $96 |
| 2023-12-31 | $93 |
| 2023-09-30 | $104 |
| 2023-06-30 | $98 |
| 2023-03-31 | $95 |
| 2022-12-31 | $105 |
| 2022-09-30 | $79 |
| 2022-06-30 | $73 |
| 2022-03-31 | $75 |
| 2021-12-31 | $73 |
| 2021-09-30 | $71 |
| 2021-06-30 | $67 |
| 2021-03-31 | $72 |
| 2020-12-31 | $61 |
| 2020-09-30 | $-167 |
| 2020-06-30 | $128 |
| 2020-03-31 | $130 |
| 2019-12-31 | $126 |
| 2019-09-30 | $-146 |
| 2019-06-30 | $120 |
| 2019-03-31 | $118 |
| 2018-12-31 | $107 |
| 2018-09-30 | $97 |
| 2018-06-30 | $106 |
| 2018-03-31 | $95 |
| 2017-12-31 | $88 |
| 2017-09-30 | $11 |
| 2017-06-30 | $110 |
| 2017-03-31 | $105 |
| 2016-12-31 | $103 |
| 2016-09-30 | $16 |
| 2016-06-30 | $93 |
| 2016-03-31 | $88 |
| 2015-12-31 | $79 |
| 2015-09-30 | $93 |
| 2015-06-30 | $94 |
| 2015-03-31 | $93 |
| 2014-12-31 | $84 |
| 2014-09-30 | $81 |
| 2014-06-30 | $77 |
| 2014-03-31 | $82 |
| 2013-12-31 | $76 |
| 2013-09-30 | $70 |
| 2013-06-30 | $75 |
| 2013-03-31 | $76 |
| 2012-12-31 | $69 |
| 2012-09-30 | $64 |
| 2012-06-30 | $94 |
| 2012-03-31 | $91 |
| 2011-12-31 | $80 |
| 2011-09-30 | $84 |
| 2011-06-30 | $129 |
| 2011-03-31 | $131 |
| 2010-12-31 | $121 |
| 2010-09-30 | $126 |
| 2010-06-30 | $111 |
| 2010-03-31 | $109 |
| 2009-12-31 | $80 |
| 2009-09-30 | $52 |
| 2009-06-30 | $40 |
| 2009-03-31 | $65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.190B | $0.665B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.384B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.892B | 183.76 |
| Hims & Hers Health (HIMS) | United States | $5.028B | 130.06 |
| Axonics (AXNX) | United States | $3.600B | 1760.50 |
| IRhythm Technologies (IRTC) | United States | $2.707B | 0.00 |
| Enovis (ENOV) | United States | $2.594B | 17.58 |
| Privia Health (PRVA) | United States | $2.547B | 213.00 |
| Omnicell (OMCL) | United States | $2.306B | 75.97 |
| 10x Genomics (TXG) | United States | $1.893B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.696B | 0.00 |
| Schrodinger (SDGR) | United States | $1.365B | 0.00 |
| Phreesia (PHR) | United States | $1.228B | 0.00 |
| Standard BioTools (LAB) | United States | $0.800B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.589B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.558B | 0.00 |
| Talkspace (TALK) | United States | $0.555B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.500B | 84.80 |
| Health Catalyst (HCAT) | United States | $0.498B | 0.00 |
| Pulmonx (LUNG) | United States | $0.294B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.230B | 0.00 |
| TruBridge (TBRG) | United States | $0.203B | 58.91 |
| American Well (AMWL) | United States | $0.135B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.108B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.045B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Movano (MOVE) | United States | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |